术前黏膜下注射地塞米松、曲马多及阿替卡因对下颌磨牙不可逆性牙髓炎下牙槽神经阻滞成功率的影响
这项随机双盲安慰剂对照试验纳入120例症状性不可逆性牙髓炎下颌磨牙患者,比较术前黏膜下注射地塞米松、曲马多或阿替卡因对下牙槽神经阻滞成功率的影响。结果显示阿替卡因组成功率显著提高至63%,地塞米松组麻醉持续时间显著延长,曲马多组与对照组无显著差异。
要点
- 术前黏膜下注射阿替卡因可显著提高下牙槽神经阻滞成功率至63%。
- 地塞米松组麻醉持续时间显著长于其他组。
- 曲马多组成功率57%与对照组37%无显著差异。
核心结论
- 症状性不可逆性牙髓炎患者术前黏膜下注射阿替卡因可提高下牙槽神经阻滞成功率。
- 地塞米松可延长下牙槽神经阻滞的麻醉持续时间。
研究设计与样本
- 随机双盲安慰剂对照临床试验,纳入120例症状性不可逆性牙髓炎下颌第一或第二磨牙患者,随机分为四组(n=30)。
主要发现
- 阿替卡因组下牙槽神经阻滞成功率为63%,显著高于对照组(p < .05)。
- 对照组成功率为37%,曲马多组为57%,地塞米松组为47%,三组间无显著差异。
- 地塞米松组麻醉持续时间显著长于其他组(p < .001)。
关键数值与推荐
- 地塞米松剂量为8 mg/2 mL,曲马多100 mg/2 mL,阿替卡因4%/2 mL,对照组注射生理盐水。
- 所有患者接受标准下牙槽神经阻滞,使用4%阿替卡因含1:200000肾上腺素。
临床怎么用
- 对于症状性不可逆性牙髓炎行根管治疗时,可术前黏膜下注射阿替卡因以提高下牙槽神经阻滞成功率。
- 地塞米松可用于需要延长麻醉持续时间的病例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To establish the effects of submucosal tramadol, dexamethasone and articaine on the success of inferior alveolar nerve blocks (IANB) during root canal treatment of mandibular molars with symptomatic irreversible pulpitis (SIP). METHODOLOGY: In this randomized double-blind, controlled clinical trial, 120 patients with the diagnosis of SIP in their mandibular first or second molars were included and randomly divided into four groups (n = 30). The control group received normal saline and three experimental groups received a single dose of dexamethasone (8 mg/2 mL), or tramadol (100 mg/2 mL) or articaine (4% / 2 mL). The pre-operative pain levels of the patients were measured with the Heft-Parker visual analogue scale (HP VAS). All patients received standard IANB of 4% articaine with 1:200000 epinephrine. Following the observation of lip numbness, submucosal injections were administered into the mucobuccal fold adjacent to the mandibular molars. After 15 min, standard root canal treatment was initiated, and the pain intensity levels recorded from the access cavity preparation to pulp extirpation were measured with HP VAS. The duration of the anaesthesia was also evaluated. The experimental groups were compared using one-way ANOVA or Kruskal-Wallis H-test. The groups that were significantly different were compared pairwise using the Tukey Multiple Comparison test. The Chi-square test was used to compare the categorical variables. RESULTS: The submucosal administration of articaine significantly increased the success rate to 63% in comparison with the control group that received submucosal saline (p < .05). The success rate of pulpal anaesthesia was 37% in the control group, 57% in the tramadol group and 47% in the dexamethasone group, with no significant difference in the success rate among these groups. In the dexamethasone group, the duration of the anaesthetic effect of IANB was significantly longer than those in the other groups (p < .001). CONCLUSIONS: In patients with SIP, pre-operative submucosal administration of articaine increased the success rate of IANB, while administration of dexamethasone increased the duration of anaesthesia. These agents can be used in cases where effective anaesthesia cannot be obtained during root canal treatments.
引用
- Aksoy F, Ege B, Tosun S, et al. The effect of pre-operative submucosal administration of dexamethasone, tramadol, articaine on the success rate of inferior alveolar nerve block on mandibular molars with symptomatic irreversible pulpitis: A randomized, double-blind placebo-controlled clinical trial. Int Endod J. 2021. PMID: 34347895. doi:10.1111/iej.13604
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。